841 related articles for article (PubMed ID: 19332205)
21. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
Das SR; Drazner MH; Dries DL; Vega GL; Stanek HG; Abdullah SM; Canham RM; Chung AK; Leonard D; Wians FH; de Lemos JA
Circulation; 2005 Oct; 112(14):2163-8. PubMed ID: 16203929
[TBL] [Abstract][Full Text] [Related]
22. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
23. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
24. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
[TBL] [Abstract][Full Text] [Related]
25. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
26. B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.
Nakamura M; Tanaka F; Sato K; Segawa T; Nagano M
J Card Fail; 2005 Dec; 11(9):705-12. PubMed ID: 16360967
[TBL] [Abstract][Full Text] [Related]
27. Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure.
Mikkelsen KV; Bie P; Møller JE; Videbaek L; Villadsen HD; Haghfelt T
Int J Cardiol; 2006 Jun; 110(3):324-33. PubMed ID: 16213609
[TBL] [Abstract][Full Text] [Related]
28. Association between changes in N-terminal pro-brain natriuretic peptide levels and changes in left ventricular mass index in stable hemodialysis patients.
Choi SY; Lee JE; Jang EH; Kim MO; Baek H; Ki CS; Park SW; Kim DJ; Huh WS; Oh HY; Kim YG
Nephron Clin Pract; 2008; 110(2):c93-100. PubMed ID: 18815449
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.
Mikkelsen KV; Bie P; Møller JE; Ryde H; Videbaek L; Haghfelt T
Scand J Clin Lab Invest; 2005; 65(8):633-47. PubMed ID: 16319038
[TBL] [Abstract][Full Text] [Related]
30. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.
Goode KM; Clark AL; Cleland JG
Int J Cardiol; 2008 Nov; 130(3):426-37. PubMed ID: 18178273
[TBL] [Abstract][Full Text] [Related]
31. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
32. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension.
Partanen N; Husso M; Vuolteenaho O; Sipola P; Ruskoaho H; Peuhkurinen K; Magga J
J Hum Hypertens; 2011 Dec; 25(12):746-51. PubMed ID: 21248782
[TBL] [Abstract][Full Text] [Related]
34. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
Edvardsen T; Rosen BD; Pan L; Jerosch-Herold M; Lai S; Hundley WG; Sinha S; Kronmal RA; Bluemke DA; Lima JA
Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
[TBL] [Abstract][Full Text] [Related]
35. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
[TBL] [Abstract][Full Text] [Related]
36. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
37. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
Cortés R; Otero MR; Morillas P; Roselló-Lletí E; Grigorian L; Martínez-Dolz L; de Burgos FG; Calabuig JR; Soria F; Lozano T; Portolés M; Bertomeu V
Am J Hypertens; 2008 Jul; 21(7):820-5. PubMed ID: 18443568
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
39. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
[TBL] [Abstract][Full Text] [Related]
40. Screening for left ventricular systolic dysfunction: the use of B-type natriuretic peptide.
Freitag MH; Vasan RS
Heart Fail Monit; 2003; 4(2):38-44. PubMed ID: 14724717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
